Predictors of Left Ventricular Recovery in Anthracycline-Induced Cardiomyopathy.

被引：0
|
作者：
Rahim, Malik T. [1 ]
Dubin, Joseph [1 ]
Bickford, Courtney L. [1 ]
Durand, Jean-Bernard [1 ]
Oliveira, Guilherme [1 ]
机构：
[1] Univ Texas MD Anderson Canc Cntr, Houston, TX USA
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Cardiomyopathy; Heart failure; Echocardiography; Ejection fraction;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A18776
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Effect of Enalapril on Preventing Anthracycline-Induced Cardiomyopathy
    Janbabai, Ghasem
    Nabati, Maryam
    Faghihinia, Mohsen
    Azizi, Soheil
    Borhani, Samaneh
    Yazdani, Jamshid
    CARDIOVASCULAR TOXICOLOGY, 2017, 17 (02) : 130 - 139
  • [32] Is Bilirubin Protective Against Anthracycline-induced Cardiomyopathy?
    Vera, Trinity
    Morgan, Timothy M.
    Jordan, Jennifer H.
    Whitlock, Matthew C.
    Kitzman, Dalane
    Hundley, W. G.
    CIRCULATION, 2014, 130
  • [33] Anthracycline-induced cardiomyopathy in a dog treated with epirubicin
    Lee, Ye-Rin
    Kang, Min-Hee
    Park, Hee-Myung
    CANADIAN VETERINARY JOURNAL-REVUE VETERINAIRE CANADIENNE, 2015, 56 (06): : 571 - 574
  • [34] Heart transplantation in patients with anthracycline-induced cardiomyopathy
    del-Castillo, Santiago L.
    Decotto, Santiago
    Fleitas, Maria M.
    Marenchino, Ricardo
    Garcia-Rivello, Hernan
    Kohan, Dana
    Pizarro, Rodolfo
    Belziti, Cesar A.
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2023, 93 (04): : 417 - 421
  • [35] Efficiency of Atorvastatin in the Protection of Anthracycline-Induced Cardiomyopathy
    Acar, Zeydin
    Kale, Abdurrahman
    Turgut, Mehmet
    Demircan, Sabri
    Durna, Kenan
    Demir, Serdar
    Meric, Murat
    Agac, Mustafa Tarik
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (09) : 988 - 989
  • [36] Cardiac resynchronisation therapy in anthracycline-induced cardiomyopathy
    Patel, Divyang
    Kumar, Anirudh
    Moennich, Laurie Ann
    Trulock, Kevin
    Nemer, David M.
    Donnellan, Eoin
    Il'Giovine, Zachary J.
    Martyn, Trejeeve
    Callahan, Thomas D.
    Hussein, Ayman A.
    Tarakji, Khaldoun G.
    Kanj, Mohamed
    Cantillon, Daniel J.
    Baranowski, Bryan
    Starling, Randall C.
    Tang, W. H. Wilson
    Wazni, Oussama M.
    Varma, Niraj
    Wilkoff, Bruce L.
    Rickard, John
    HEART, 2022, 108 (04) : 274 - 278
  • [37] Proteomic analysis in the study of anthracycline-induced cardiomyopathy
    Lenco, J.
    Sterba, M.
    Mazurova, Y.
    Popelova, O.
    Brychta, M.
    Stulik, J.
    Gersl, V.
    MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) : S83 - S83
  • [38] Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
    Felix Sebastian Nettersheim
    Johannes David Schlüter
    Wiebke Kreuzberg
    Dennis Mehrkens
    Simon Grimm
    Harshal Nemade
    Simon Braumann
    Alexander Hof
    Henning Guthoff
    Vera Peters
    Friedrich Felix Hoyer
    Yulia Kargapolova
    Jan-Wilm Lackmann
    Stefan Müller
    Christian P. Pallasch
    Michael Hallek
    Agapios Sachinidis
    Matti Adam
    Holger Winkels
    Stephan Baldus
    Simon Geißen
    Martin Mollenhauer
    Basic Research in Cardiology, 118
  • [39] Cardiac Toxicity Using angiotensin-converting enzyme inhibitors to prevent anthracycline-induced left ventricular dysfunction and cardiomyopathy
    Kobza, Catherine Andrea
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2021, 25 (03) : 259 - 266
  • [40] Case report: Left ventricular noncompaction cardiomyopathy.
    Martinez, J.
    Franqui, H.
    Calderon, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S251 - S251
12345